Search

Search Constraints

You searched for: Author/Creator Alexander, Tobias

Search Results

1. 02.34 Enhanced conventional cd4+ t cell proliferation in sle is associated with up-regulation of microrna-182 and increased il-7 receptor signalling. (1st March 2017)

2. 06.08 Low-dose il-2 therapy in refractory sle: results from a single centre phase i/iia clinical trial. (1st March 2017)

3. 06.14 Proteasome inhibition with bortezomib in sle promotes therapeutically relevant depletion of short- and long-lived plasma cells but does not prevent their regeneration. (1st March 2017)

4. A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE. (17th January 2020)

5. A2.6 Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?. (25th February 2013)

6. A3.22 Upregulated microRNA-182 Expression is Associated with Enhanced Conventional CD4+ T Cell Proliferation in SLE. (25th February 2013)

7. A3.26 Proteasome inhibition with bortezomib in refractory SLE inhibits type I interferon and depletes plasma cells but does not inhibit their regeneration. (31st January 2014)

8. A8.16 T helper lymphocytes and monocytes as biosensors of type I interferon responses in viral infection and autoimmunity. (31st January 2014)